+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic SWOT Analysis Review

  • ID: 4278989
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


NeuroVive Pharmaceutical AB (NeuroVive), formerly Neuro Pharma is a pharmaceutical company that research and develops pharmaceuticals to protect mitochondria from post acute traumatic injury. The company’s drug development technology platform include cyclosporine-A for the treatment of acute traumatic conditions. It conducts clinical trials of ciclomulsion and neuroSTAT in humans. NeuroVive is developing additional variants of cyclophilin-D-inhibiting cyclosporines based pharmaceuticals. The company also has development platforms to develop drugs for treatment of ischemic stroke. Its research and development programs are conducted both in-house and in collaboration with various foreign partners. NeuroVive is headquartered in Lund, Sweden.

NeuroVive Pharmaceutical AB Key Recent Developments

Feb 20, 2018: NeuroVive Pharmaceutical Year End Report January - December 2017
Jan 03, 2018: NeuroVive to Present at the 10th Annual Biotech Showcase Conference
Nov 21, 2017: NeuroVive Pharmaceutical Interim Report January - September 2017
Nov 07, 2017: NeuroVive Board Chair Resigns, New Chair Elected
Oct 18, 2017: NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

This comprehensive SWOT profile of NeuroVive Pharmaceutical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NeuroVive Pharmaceutical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • NeuroVive Pharmaceutical AB - Key Information
  • NeuroVive Pharmaceutical AB - Overview
  • NeuroVive Pharmaceutical AB - Key Employees
  • NeuroVive Pharmaceutical AB - Key Employee Biographies
  • NeuroVive Pharmaceutical AB - Key Operational Heads
  • NeuroVive Pharmaceutical AB - Major Products and Services
  • NeuroVive Pharmaceutical AB - History
  • NeuroVive Pharmaceutical AB - Company Statement
  • NeuroVive Pharmaceutical AB - Locations And Subsidiaries
  • NeuroVive Pharmaceutical AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • NeuroVive Pharmaceutical AB - Business Description
  • NeuroVive Pharmaceutical AB - Corporate Strategy
  • NeuroVive Pharmaceutical AB - SWOT Analysis
  • SWOT Analysis - Overview
  • NeuroVive Pharmaceutical AB - Strengths
  • NeuroVive Pharmaceutical AB - Weaknesses
  • NeuroVive Pharmaceutical AB - Opportunities
  • NeuroVive Pharmaceutical AB - Threats
  • NeuroVive Pharmaceutical AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • NeuroVive Pharmaceutical AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • NeuroVive Pharmaceutical AB, Key Information
  • NeuroVive Pharmaceutical AB, Key Ratios
  • NeuroVive Pharmaceutical AB, Share Data
  • NeuroVive Pharmaceutical AB, Major Products and Services
  • NeuroVive Pharmaceutical AB, History
  • NeuroVive Pharmaceutical AB, Key Employees
  • NeuroVive Pharmaceutical AB, Key Employee Biographies
  • NeuroVive Pharmaceutical AB, Key Operational Heads
  • NeuroVive Pharmaceutical AB, Other Locations
  • NeuroVive Pharmaceutical AB, Subsidiaries
  • NeuroVive Pharmaceutical AB, Key Manufacturing facilities
  • NeuroVive Pharmaceutical AB, Key Competitors
  • NeuroVive Pharmaceutical AB, SWOT Analysis
  • NeuroVive Pharmaceutical AB, Ratios based on current share price
  • NeuroVive Pharmaceutical AB, Annual Ratios
  • NeuroVive Pharmaceutical AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • NeuroVive Pharmaceutical AB, Performance Chart
  • NeuroVive Pharmaceutical AB, Ratio Charts
Note: Product cover images may vary from those shown